These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
283 related items for PubMed ID: 4991821
1. [Improved prognosis of fetal erythroblastosis through the variation of prophylactic and therapeutic measures]. Verron G, Radzuweit H, Schubert W, Brockmann J. Dtsch Gesundheitsw; 1970 Oct 01; 25(40):1906-10. PubMed ID: 4991821 [No Abstract] [Full Text] [Related]
2. [Diagnostic measures in the prevention of Rh sensitization with anti D immunoglobulin]. Jung K. Dtsch Med Wochenschr; 1969 Aug 15; 94(33):1654-5. PubMed ID: 4183534 [No Abstract] [Full Text] [Related]
5. [Anti-D treatment after mismatched transfusion: prevention of Rh sensitization]. Schellong G, Grimm W. Dtsch Med Wochenschr; 1970 Dec 18; 95(51):2555-9. PubMed ID: 4998366 [No Abstract] [Full Text] [Related]
6. [Preliminary results of the use of anti-D immuno-gamma-globulin in the prevention of Rh factor isoimmunization]. Gherardi A. Ig Mod; 1970 Dec 18; 63(1):47-56. PubMed ID: 4991878 [No Abstract] [Full Text] [Related]
8. The future of Rh immune globulin. Gorman JG. Ann Ostet Ginecol Med Perinat; 1970 Jul 18; 92(7):422-6. PubMed ID: 5003518 [No Abstract] [Full Text] [Related]
9. [Diagnostic and therapeutic measures in materno-fetal Rh-factor isoimmunization]. Paladini A, Di Martino D, De Luca P, Rascio B, Di Lieto A. Arch Ostet Ginecol; 1969 Dec 18; 74(6):476-94. PubMed ID: 5000274 [No Abstract] [Full Text] [Related]
10. [Immunological prevention of materno-fetal iso-immunization due to Rh-incompatibility. Socio-economic aspects]. Granese D, Volpe A. Arch Ostet Ginecol; 1970 Dec 18; 75(4):356-62. PubMed ID: 4999055 [No Abstract] [Full Text] [Related]
11. [Causes of regression in the exchange transfusion of newborn infants in Styria]. Rosegger VH, Teubl I, Stern E, Müller WD, Haidvogl M. Wien Med Wochenschr; 1978 May 30; 128(10):298-301. PubMed ID: 96610 [No Abstract] [Full Text] [Related]
12. Advances in treatment of RH negative blood incompatibility of mothers and infants. Chinn PC, Mueller JM. Ment Retard; 1971 Feb 30; 9(1):12-5. PubMed ID: 4995878 [No Abstract] [Full Text] [Related]
13. [Preliminary experiences with the prevention of Rh sensitization]. Aeppli H, Nwebube G. Gynaecologia; 1969 Feb 30; 168(6):481-3. PubMed ID: 4993890 [No Abstract] [Full Text] [Related]
15. Some epidemiological aspects of the prevention of Rh isoimmunization. Walker W. Ann Ostet Ginecol Med Perinat; 1970 Jul 30; 92(7):431-5. PubMed ID: 5003520 [No Abstract] [Full Text] [Related]
16. [Current status of neonatal hemolytic disease caused by Rh incompatibility]. Uhlig R, Menzel K. Z Arztl Fortbild (Jena); 1986 Jul 30; 80(4):143-8. PubMed ID: 3087070 [No Abstract] [Full Text] [Related]
18. [Problem of the dose of immunoglobulins in the prevention of hemolytic disease of newborn due to materno-fetal incompatibility of antigen D, in case of massive feto-maternal hemorrhage]. Mattone PG, Meriggi E, De Martin G. Minerva Ginecol; 1972 May 30; 24(7):337-41. PubMed ID: 4211573 [No Abstract] [Full Text] [Related]
19. [Prevention of Rhesus sensitization using anti-D, ten years after initiation of the first studies]. Schneider J. Z Geburtshilfe Perinatol; 1972 Feb 30; 176(1):2-16. PubMed ID: 4553933 [No Abstract] [Full Text] [Related]
20. [Practical problems in prevention of Rh-sensitization with immunological methods]. Althoff W, Schellong G, Stahl M. Minerva Med; 1969 Jul 28; 60(59):2905-15. PubMed ID: 4978556 [No Abstract] [Full Text] [Related] Page: [Next] [New Search]